Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
17.51x2.02x-2.54x3.84x10.32x11.38x0.58% 68.8B
27.36x4.11x2.09x5.63x16.53x20.89x0.58% 55.21B
35.27x7.08x0.69x11.95x22.64x26.61x-.--% 43.46B
-46.27x2.52x0.36x3.25x9.6x11.21x3.32% 41.18B
-9.21x5.42x-0.48x13.41x-8.22x-7.77x-.--% 31.65B
31.34x1.61x-1.24x3.56x11.02x12.92x-.--% 30.37B
17.13x3.43x2.29x3.29x9.96x9.78x-.--% 23.58B
56.27x5.53x0.3x6.08x42.2x39.03x-.--% 19.33B
26.8x3.75x0.02x5.49x14.74x20.37x-.--% 17.16B
-35.54x-6.21x0.85x16.63x-50.5x-52.95x-.--% 15.27B
-125.69x13228.81x2.73x12.92x-114.56x-127.57x-.--% 12.85B
61.75x25.18x0.58x37.5x53.04x54.7x0.15% 11.93B
17.13x - 0.18x3.64x13.33x15.98x-.--% 11.66B
47.81x - 3.76x - - - -.--% 10.87B
73.49x5.2x-0.94x - - - - 6.95B
11.89x1.04x0.41x1.81x7.29x9.77x2.82% 6.24B
14.54x1.34x-0.21x2.59x6.7x8.11x1.55% 5.83B
28.21x - 1.38x7.57x20.1x24x0.37% 5.74B
-44.98x - -0.81x - - - - 5.67B
Average 10.78x 886.05x 0.50x 8.70x 4.01x 4.78x 0.55% 22.3B
Weighted average by Cap. 11.40x 440.04x 0.21x 7.57x 7.80x 9.17x 0.58%
Biopharmaceuticals